Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?

This study has been completed.

First Received: October 27, 1999 Last Updated: June 23, 2005 History of Changes

Sponsor:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00000473

Purpose

To determine whether a dietary supplement of n-3 polyunsaturated fatty acids (PUFAs) derived from fish oil would decrease the restenosis rate in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).

Condition	Intervention	Phase
Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia	Behavioral: dietary supplements Drug: fatty acids, omega-3 Behavioral: diet, fat-restricted	Phase III

Study Type:	Interventional
Study Design:	Prevention, Randomized, Double-Blind

Resource links provided by NLM:

MedlinePlus related topics: Angioplasty Coronary Artery Disease Dietary Supplements Diets Heart Diseases

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:

July 1989

Show Detailed Description

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Men and women with coronary heart disease in the native coronary arteries. Patients were symptomatic or had 50 percent or greater stenosis as defined by coronary angiography.

Patients had not undergone prior angioplasty.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000473

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Investigator:

Alexander Leaf

Massachusetts General Hospital

More Information

Publications:

Leaf A, Jorgensen MB, Jacobs AK, Cote G, Schoenfeld DA, Scheer J, Weiner BH, Slack JD, Kellett MA, Raizner AE, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation. 1994 Nov;90(5):2248-57.

Study ID Numbers:	62
Study First Received:	October 27, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00000473 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Arterial Occlusive Diseases
Coronary Disease
Pathologic Processes
Heart Diseases
Myocardial Ischemia

Vascular Diseases
Cardiovascular Diseases
Arteriosclerosis
Ischemia
Coronary Artery Disease

ClinicalTrials.gov processed this record on November 09, 2009